Cosmetics manufacturing facility reviewed as part of supplier qualification

Supplier Check: What Should a Skincare Buyer Verify Before Manufacturing in China?

“Is it safe to manufacture skincare in China?” sounds like a sensible sourcing question. It is also too broad to protect a project.

A country is not a quality system. Two factories in the same industrial zone can have very different licensed scopes, documentation habits, change controls, equipment, and release practices. The more useful question is whether the exact supplier, site, product, package, and market can be connected by evidence.

Supplier signal this week

Do not qualify a skincare manufacturer from a badge wall. Qualify one evidence chain: legal factory, licensed scope, approved product, controlled production, batch release, and destination-market responsibilities.

This distinction matters because a manufacturing licence, a GMP certificate, a formula sample, and a market registration answer different questions. None of them, alone, proves that the final product will match the approved brief.

A licence is the starting point, not the conclusion

China's National Medical Products Administration states that cosmetic manufacturing is subject to licensing, with the application reviewed against the required conditions and, where appropriate, an on-site inspection. The licence also has a defined production scope.

For a buyer, that means the first check should be literal. Match the legal manufacturer name, factory address, licence number, validity period, and production scope to the site and product format under discussion. A trading company name, an old PDF, or a certificate from another group entity is not the same thing.

Weak check

“The supplier sent a licence.”

The document may be genuine but still belong to the wrong entity, address, scope, or period.

Useful check

“Does this document cover this factory and this product format?”

The evidence is tied to the legal site and the work the project actually requires.

A certificate logo needs five pieces of context

ISO 22716 provides guidelines for cosmetic production, control, storage, and shipment. That makes it relevant to supplier qualification, but a logo in a presentation is not enough. Ask for the certificate holder, site address, scope, issuing body, and validity status.

Then separate quality-system evidence from product evidence. A quality-system certificate can support confidence in how a site is managed. It does not, by itself, approve a formula, prove a claim, confirm package compatibility, or satisfy every destination market.

Factory-side note

If one document is being used to answer every quality and compliance question, the categories have probably been mixed together.

A polished sample does not prove repeatable production

A good sample proves that somebody can make one good sample. Commercial repeatability starts when both sides control what “approved” means.

The working record should identify the formula version, sensory target, approved reference sample, fill weight, component specification, artwork version, test plan, acceptance criteria, and authorised deviations. Without that record, a later disagreement becomes a memory contest: which viscosity, pump output, colour, fragrance strength, or carton finish was actually approved?

Cosmetic production vessels inspected during a controlled manufacturing process

Production equipment matters, but the buyer also needs the records that connect approved specifications to each manufactured batch.

The six-layer evidence chain

Evidence layer What to verify What it does not prove alone
Legal identity Entity, address, licence, validity, actual manufacturing site That the proposed product is within scope
Licensed and audited scope Product category, site scope, certificate holder and status Finished-product performance or market acceptance
Product specification Formula version, reference sample, acceptance limits and test plan That the selected package will remain compatible
Packaging system Component codes, supplier, artwork, dosing and compatibility That substitutions can be made without review
Batch control and release Batch record, in-process checks, results, release status and traceability That every claim is substantiated for every market
Market responsibility Brand, importer, responsible person, manufacturer and file ownership That registration equals government approval

“FDA compliant” is not a responsibility map

Destination-market work must be checked separately. In the United States, FDA explicitly states that facility registration and product listing are not approval programmes, and that it does not issue certificates for those submissions. The manufacturer or distributor remains legally responsible for product safety.

In the European Union, the Cosmetics Regulation requires manufacture to comply with good manufacturing practice, while the Product Information File includes the manufacturing method and a statement of GMP compliance. Those obligations sit within a broader product and responsible-person framework.

So ask a practical question: who owns each action and record? The brand, importer, responsible person, testing laboratory, packaging supplier, and factory may all hold different parts. “The factory handles compliance” is not specific enough for a purchase order.

Run the check in three stages

01 / Before sampling

Confirm legal entity, site, licensed scope, quality-system evidence, destination market, product category, intended claims, package format, and who will own regulatory files.

02 / Before approval

Freeze the formula and package versions, reference sample, specifications, artwork, compatibility plan, test plan, claim boundary, and change-approval route.

03 / Before production and shipment

Confirm approved components, production instruction, batch traceability, in-process checks, release evidence, coding, retained samples, deviation handling, and shipment documents.

Five red flags that deserve a second question

  1. One vague certificate is presented as proof for every product and market.
  2. A registration or listing is described as government product approval.
  3. A component or raw-material substitution can be made because it is “equivalent,” without buyer approval.
  4. A final quotation is offered before the market, package, tests, and claim scope are defined.
  5. Sample changes are made without a version number or written comparison to the approved reference.

A reliable supplier does not remove the buyer's responsibility. It makes each handoff inspectable. The strongest qualification file is not the one with the most logos. It is the one that lets a new person trace the product from legal factory to approved specification, controlled batch, released shipment, and market owner without relying on somebody's memory.

Primary sources and further reading

  1. China NMPA, Good Manufacturing Practice for Cosmetics.
  2. China NMPA, Provisions for the Supervision and Administration of Cosmetics Manufacturing and Marketing.
  3. ISO, ISO 22716:2007 Cosmetics — Good Manufacturing Practices.
  4. US FDA, Registration and Listing of Cosmetic Product Facilities and Products.
  5. US FDA, Product Testing of Cosmetics.
  6. European Union, Regulation (EC) No 1223/2009 on cosmetic products.

This article provides general supplier-qualification and product-development information. Legal, regulatory, testing, documentation, and market responsibilities depend on the product and destination market.

Back to blog

More Stories about Us